Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ICU Medical, Inc. - Common Stock (NQ: ICUI )

163.61 +3.45 (+2.15%)
Streaming Delayed Price Updated: 11:05 AM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ICU Medical, Inc. - Common Stock

< Previous 1 2 3 Next >
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers. 
Via StockStory
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including... 
Via StockStory
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers. 
Via StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems... 
Via StockStory
A Glimpse Into The Expert Outlook On ICU Medical Through 4 Analysts
Via Benzinga
Breaking Down ICU Medical: 4 Analysts Share Their Views
Via Benzinga
ICUI Stock Earnings: ICU Medical Beats EPS, Beats Revenue for Q2 2024
ICUI stock results show that ICU Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
Via Benzinga
ICUI Stock Earnings: ICU Medical Beats EPS, Beats Revenue for Q1 2024
ICUI stock results show that ICU Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Recap: ICU Medical Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
ICU Medical's Earnings: A Preview
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Analyst Scoreboard: 4 Ratings For ICU Medical
Via Benzinga
ICU Medical Recalls ParaPAC Plus Ventilators Due To Loose Outlet Connector That Can Cause Injury Or Death
Smiths Medical, a subsidiary of ICU Medical, recalls ParaPAC Plus P300 and P310 ventilators; they pose risks of injury or death. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defects
Smiths Medical, a subsidiary of ICU Medical, recalls Bivona neonatal, pediatric, and adult tracheostomy tubes due to a defect that may lead to serious injury or death following the FDA's classification... 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Deep Dive Into ICU Medical Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
ICU Medical Earnings Perspective: Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ICU Medical Stock Plunged Today - Here's Why
ICU Medical, Inc. (NASDAQ: ICUI) shares traded lower on Tuesday following mixed third-quarter results.  
Via Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Zscaler To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
Stifel raised the price target for XPO, Inc. (NYSE: XPO) from $48 to $51. Stifel analyst J. Bruce Chan downgraded the stock from Buy to Hold. XPO shares fell 1.5% to $47.72 in pre-market trading. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.